Delivery Order SPE2DR25D3103-SPE2DR26F0A0K
Award Date 1/23/26
Potential Completion Date 1/26/26
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,259.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package) on January 21, 2026, with ultimate completion by January 22, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,754.83 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to...
- The Defense Logistics Agency awarded a delivery order valued at approximately $26,000 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with completion expected by July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $23,087.13 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 21, 2026, with completion expected by January 22, 2026. This contract was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the parent organization Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $8,201.71 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on January 12, 2026, with completion scheduled for January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare systems to manage nausea and vomiting, particularly in acute care...
- The Defense Logistics Agency awarded a delivery order valued at $2,210.28 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) on January 16, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 20, 2026. The awardee will perform at its corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea and vomiting,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,921.49 to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 22, 2026, and performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $6,859.46 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This non-set-aside, firm fixed-price contract was competitively awarded on June 7, 2025, with an ultimate completion date of June 9, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. Ondansetron is a commonly...
- The Defense Logistics Agency awarded a $15,452.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8 mg tablets (30-count units), with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,854.40 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ondansetron ODT 8mg in a quantity of 30 units. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea and...